Drug:
Reaction: HYPERTENSION
20250101 - 20251231
No. 501 - 600
No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
501 | 25076588 |
JP |
8 | 1 |
Hypertension, |
||||
PEMBROLIZUMAB, |
||||
502 | 25076631 |
JP |
8 | 1 |
Cardiac failure congestive, Hypertension, |
||||
PEMBROLIZUMAB, |
||||
503 | 25076734 |
FR |
76 | 1 |
Hypertension, Cardiac failure, |
||||
ENZALUTAMIDE, BISOPROLOL FUMARATE, CANDESARTAN CILEXETIL, FUROSEMIDE, DAPAGLIFLOZIN, DULAGLUTIDE, PRAVASTATIN SODIUM, |
||||
504 | 25076739 |
US |
||
Unevaluable event, Hyperlipidaemia, Mental disorder, Obesity, Asthenia, Fatigue, Respiratory disorder, Hypertension, Off label use, |
||||
RITUXIMAB, |
||||
505 | 25076780 |
US |
72 | 1 |
Cholelithiasis, Necrosis, Pain, Device issue, Abdominal pain, Hypertension, |
||||
RISANKIZUMAB-RZAA, RISANKIZUMAB-RZAA, |
||||
506 | 25066021 |
CN |
57 | 2 |
Hypertension, Blood glucose increased, |
||||
METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, GLYBURIDE, |
||||
507 | 25066024 |
US |
55 | 1 |
Hypertension, |
||||
EVOLOCUMAB, |
||||
508 | 25066073 |
CA |
||
Blood pressure systolic increased, Dizziness, Dyspnoea, Hypertension, Blood pressure systolic decreased, |
||||
BENRALIZUMAB, MONTELUKAST, BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, TIOTROPIUM BROMIDE, |
||||
509 | 25066203 |
CA |
47 | 2 |
Cold urticaria, Body temperature fluctuation, Diabetes mellitus, Fear, Mastocytosis, Respiratory rate decreased, Tryptase increased, Weight decreased, Drug hypersensitivity, Hypertension, Palpitations, Oedema, Rash, Urticaria, Therapeutic product effect decreased, |
||||
CELECOXIB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, CELECOXIB, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, EPINEPHRINE, |
||||
510 | 25066223 |
CA |
64 | 2 |
Chest discomfort, Cognitive disorder, Drug hypersensitivity, Dyspnoea, Dystonia, Eye disorder, Feeling cold, Heart rate irregular, Muscle contractions involuntary, Hepatomegaly, Hypertension, Fatigue, Insomnia, Muscular weakness, Musculoskeletal stiffness, Neurological symptom, Nocturia, Peripheral swelling, Pollakiuria, Polyuria, Thirst, White blood cell disorder, Heart rate increased, Gait disturbance, Dry skin, Tardive dyskinesia, Weight increased, Palpitations, Somnolence, Rash, Tremor, Nausea, Headache, |
||||
VALPROIC ACID, ARIPIPRAZOLE, ARIPIPRAZOLE, HYDROCHLOROTHIAZIDE, LORAZEPAM, OLANZAPINE, |
||||
511 | 25066224 |
CA |
70 | 2 |
Back injury, Blood pressure systolic increased, Body temperature decreased, Concomitant disease aggravated, Coronary artery occlusion, Discomfort, Drug hypersensitivity, Fibromyalgia, Asthenia, Gangrene, Illness, Injection site bruising, Injection site mass, Injection site pain, Malaise, Migraine, Muscle spasms, Overgrowth bacterial, Pain, Post procedural diarrhoea, Procedural pain, Influenza, Irritable bowel syndrome, Hypertension, Abdominal pain upper, Norovirus infection, Insomnia, Diarrhoea, Nausea, Urticaria, Vomiting, |
||||
AMOXICILLIN, METOCLOPRAMIDE HYDROCHLORIDE, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, DARIFENACIN HYDROBROMIDE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, FAMOTIDINE, METOPROLOL TARTRATE, METOPROLOL, NABILONE, RAMIPRIL, SPIRONOLACTONE, |
||||
512 | 25066486 |
US |
2 | |
Ankylosing spondylitis, Hypertension, Contusion, Product distribution issue, Product use issue, |
||||
CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, |
||||
513 | 25066562 |
US |
50 | 2 |
Hypertension, |
||||
APREMILAST, |
||||
514 | 25066797 |
CA |
65 | 1 |
Blood glucose increased, Blood pressure fluctuation, Blood pressure increased, Blood pressure systolic increased, Chest discomfort, Diabetes mellitus, Dyspnoea, Heart rate abnormal, Hypertension, Muscular weakness, Urticaria, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, AMLODIPINE, BISOPROLOL FUMARATE, CANAGLIFLOZIN, EZETIMIBE, FUROSEMIDE, LIRAGLUTIDE, SPIRONOLACTONE, TERAZOSIN, TERAZOSIN HYDROCHLORIDE, INSULIN DEGLUDEC, |
||||
515 | 25066865 |
CA |
85 | 2 |
Cataract, Condition aggravated, Hypertension, Eye pruritus, |
||||
BRINZOLAMIDE, TIMOLOL MALEATE, TIMOLOL MALEATE OPHTHALMIC, |
||||
516 | 25066954 |
CA |
65 | 2 |
Angina pectoris, Headache, Pain in extremity, Chest pain, Epistaxis, Hypertension, |
||||
GUSELKUMAB, GUSELKUMAB, GUSELKUMAB, |
||||
517 | 25067214 |
US |
71 | 2 |
Skin laceration, Dizziness, Hypertension, Musculoskeletal discomfort, Drug ineffective, |
||||
APIXABAN, APIXABAN, |
||||
518 | 25067284 |
CA |
2 | |
Hypertension, Abdominal pain upper, Sleep disorder, Depression, Renal failure, |
||||
MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, |
||||
519 | 25067301 |
US |
||
Blindness, Hypertension, Blood cholesterol abnormal, Headache, Gastrointestinal disorder, Intervertebral disc protrusion, |
||||
APIXABAN, |
||||
520 | 25067614 |
US |
2 | |
Hypertension, Palpitations, |
||||
ACETAMINOPHEN, DEXTROMETHORPHAN HYDROBROMIDE, |
||||
521 | 25067774 |
US |
34 | 2 |
Jaundice, Weight decreased, Hypertension, Hypersensitivity, Product use in unapproved indication, |
||||
DOXYCYCLINE, DOXYCYCLINE HYCLATE, |
||||
522 | 25067866 |
CA |
70 | 1 |
Hypertension, |
||||
ZOLEDRONIC ACID, |
||||
523 | 25067893 |
CA |
2 | |
Helicobacter infection, Lower limb fracture, Lupus vulgaris, Sleep disorder, Eye injury, Headache, Blood cholesterol increased, Confusional state, Abdominal pain upper, Infusion related reaction, Therapeutic response decreased, Pain, Drug ineffective, Vomiting, Psoriatic arthropathy, Anxiety, Glossodynia, Lower respiratory tract infection, Irritable bowel syndrome, Condition aggravated, Product use issue, Rheumatoid arthritis, Leukopenia, Contraindicated product administered, Sleep disorder due to general medical condition, insomnia type, Pericarditis, Fatigue, General physical health deterioration, Dizziness, Folliculitis, Anti-cyclic citrullinated peptide antibody positive, Type 2 diabetes mellitus, Road traffic accident, Deep vein thrombosis postoperative, Stomatitis, Urticaria, Hand deformity, Injury, Discomfort, Alopecia, Ulcer haemorrhage, Drug hypersensitivity, Maternal exposure during pregnancy, Synovitis, Impaired healing, Hypertension, Prescribed overdose, Gastrointestinal disorder, Product use in unapproved indication, Diarrhoea, Rash pruritic, Pemphigus, Peripheral swelling, Nasopharyngitis, Muscle injury, Intentional product use issue, Pyrexia, Systemic lupus erythematosus, Weight increased, Sinusitis, Gait inability, Duodenal ulcer perforation, Asthma, Chest pain, Off label use, Swelling, Autoimmune disorder, Fibromyalgia, Drug intolerance, Liver disorder, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, HYDROXYCHLOROQUINE, TOFACITINIB, TOFACITINIB, OXYCODONE, LEFLUNOMIDE, ADALIMUMAB, ABATACEPT, ABATACEPT, TOCILIZUMAB, TOCILIZUMAB, ALENDRONATE SODIUM, PREDNISONE, PREDNISONE, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CALCIUM GLUCONATE, INFLIXIMAB, INFLIXIMAB, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CALCIUM CARBONATE, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, CERTOLIZUMAB PEGOL, VITAMIN C, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, USTEKINUMAB, MAGNESIUM, CAFFEINE, LORAZEPAM, ERGOCALCIFEROL, LORAZEPAM, LANSOPRAZOLE, LISINOPRIL, |
||||
524 | 25067969 |
BE |
73 | 1 |
Dyskinesia, Malaise, Hypertension, Syncope, |
||||
BEMPEDOIC ACID, AMLODIPINE, NEBIVOLOL, NEBIVOLOL HYDROCHLORIDE, TAMSULOSIN HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, |
||||
525 | 25068095 |
FR |
14 | 1 |
Disease progression, Drug ineffective for unapproved indication, Thrombocytopenia, Proteinuria, Hypertension, Diarrhoea, |
||||
ETOPOSIDE, AXITINIB, BEVACIZUMAB, |
||||
526 | 25068108 |
FR |
14 | 2 |
Hypothyroidism, Disease progression, Drug ineffective for unapproved indication, Thrombocytopenia, Hypertension, Fatigue, Diarrhoea, Anaemia, |
||||
ETOPOSIDE, ETOPOSIDE, AXITINIB, CARBOPLATIN, THIOTEPA, BEVACIZUMAB, ABEMACICLIB, |
||||
527 | 25068120 |
US |
||
Hypertension, Incorrect dose administered, |
||||
RELUGOLIX, |
||||
528 | 25068153 |
71 | 1 | |
Hypertension, Hyperlipidaemia, Palpitations, Gastrooesophageal reflux disease, Myocardial ischaemia, Hypervolaemia, Acute kidney injury, |
||||
CISPLATIN, GEMCITABINE HYDROCHLORIDE, |
||||
529 | 25068175 |
US |
31 | 2 |
Hypertension, |
||||
NIRMATRELVIR AND RITONAVIR, |
||||
530 | 25068258 |
CH |
81 | 1 |
Hypertensive crisis, Hypertension, Headache, Freezing phenomenon, Device issue, Mobility decreased, |
||||
TRAZODONE HYDROCHLORIDE, |
||||
531 | 25068491 |
US |
2 | |
Cardiac failure chronic, Dyspnoea, Myocardial infarction, Chronic kidney disease, Memory impairment, Hypertension, Urinary tract infection, |
||||
SACUBITRIL AND VALSARTAN, |
||||
532 | 25068998 |
US |
2 | |
Hypertension, Drug ineffective, |
||||
DUPILUMAB, ALBUTEROL SULFATE, FLUTICASONE PROPIONATE, CETIRIZINE HYDROCHLORIDE, |
||||
533 | 25069344 |
US |
1 | |
Pneumonia aspiration, Metapneumovirus infection, Hypertension, |
||||
TROFINETIDE, |
||||
534 | 25069394 |
US |
69 | 1 |
Urticaria, Hypertension, Pruritus, |
||||
IMMUNE GLOBULIN INTRAVENOUS (HUMAN) 10%, |
||||
535 | 25069411 |
US |
45 | 2 |
Suspected suicide attempt, Depressed level of consciousness, Agitation, Bradycardia, Hyperthermia, Hypertension, Nervous system disorder, |
||||
CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES, |
||||
536 | 25069424 |
US |
2 | |
Hallucination, Hypertension, Cardiac disorder, Gait disturbance, |
||||
PIMAVANSERIN TARTRATE, |
||||
537 | 25069597 |
JP |
72 | 1 |
Subarachnoid haemorrhage, Hypertension, |
||||
LENVATINIB, LENVATINIB, LENVATINIB, SULFASALAZINE, METHYLPREDNISOLONE, CALCITRIOL, CALCITRIOL CAPSULES 0.25 MCG, CALCITRIOL CAPSULES 0.5 MCG, LANSOPRAZOLE, ATENOLOL, VALSARTAN, DICLOFENAC SODIUM, TOLVAPTAN, MAGNESIUM OXIDE, URSODIOL, URSOSIOL, AMLODIPINE, RISEDRONATE SODIUM, CISPLATIN, |
||||
538 | 25069760 |
US |
67 | 2 |
Hypertension, Chest pain, |
||||
NIRMATRELVIR AND RITONAVIR, ACETAMINOPHEN, GUAIFENESIN, AND PHENYLEPHRINE HYDROCHLORIDE, ACETAMINOPHEN, LEVOTHYROXINE SODIUM, |
||||
539 | 25069763 |
US |
61 | 2 |
Nasopharyngitis, Pain, Abnormal sensation in eye, Fatigue, Hypertension, Diarrhoea, Headache, |
||||
NATALIZUMAB, |
||||
540 | 25069792 |
US |
40 | 2 |
Hypertension, Hemiparesis, |
||||
ASCIMINIB, |
||||
541 | 25070001 |
ES |
76 | 2 |
Cataract, Malaise, Tremor, Blood glucose decreased, Hyperhidrosis, Hypoacusis, Abscess limb, Localised infection, Memory impairment, Hypertension, Haematological infection, Cardiac disorder, Headache, Nervousness, Limb discomfort, Eye pruritus, Eye pain, Tendon discomfort, Fatigue, Dyspnoea, Pain in extremity, Back pain, Pain, Visual impairment, Blood glucose fluctuation, Hyperglycaemia, Incorrect dose administered, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, INSULIN GLARGINE-YFGN, INSULIN GLARGINE, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, EMPAGLIFLOZIN, |
||||
542 | 25070328 |
IN |
31 | 2 |
New onset diabetes after transplantation, Hypertension, Hepatic enzyme abnormal, Product prescribing error, |
||||
TACROLIMUS, TACROLIMUS OINTMENT 0.1%, TACROLIMUS EXTENDED-RELEASE CAPSULES, MYCOPHENOLIC ACID, |
||||
543 | 25070747 |
US |
||
Chest pain, Hypotension, Hypertension, Bradycardia, Electrocardiogram QT prolonged, Electrocardiogram abnormal, Tachycardia, Conduction disorder, Depressed level of consciousness, Rhabdomyolysis, Syncope, Intentional product misuse, Electrolyte imbalance, Blood creatinine increased, Dizziness, Vertigo, Visual impairment, Somnolence, Lethargy, Agitation, Dysarthria, Tremor, Headache, Tinnitus, Muscular weakness, Neurological symptom, Vomiting, Nausea, Diarrhoea, Dyspnoea, Cyanosis, Erythema, Flushing, Hyperhidrosis, Drug ineffective, Adverse drug reaction, Therapeutic product effect incomplete, Accidental exposure to product, Accidental exposure to product by child, Medication error, |
||||
IVABRADINE, |
||||
544 | 25070876 |
US |
40 | |
Cardiac failure, Suicide attempt, Renal disorder, Cardiac failure congestive, Mental disorder, Hyperlipidaemia, Left ventricular enlargement, Left ventricular hypertrophy, Left ventricular dysfunction, Myocardial infarction, Drug abuse, Hypertension, Pulmonary oedema, Vision blurred, Dyspnoea exertional, Chest discomfort, Dizziness, Chest pain, Fatigue, Oedema peripheral, Palpitations, Dyspnoea, Overdose, Product dose omission issue, Chronic kidney disease, Essential hypertension, |
||||
DAPAGLIFLOZIN, HYDRALAZINE HYDROCHLORIDE, CLONIDINE, |
||||
545 | 25070992 |
CA |
43 | 2 |
Abdominal pain, Anaemia, Asthma, Benign uterine neoplasm, Blood iron decreased, Blood pressure systolic decreased, Bruxism, COVID-19, Cough, Discomfort, Dizziness, Drug ineffective, Ear pain, Fatigue, Feeling cold, Headache, Heart rate increased, Hypertension, Illness, Incorrect dose administered, Infection, Influenza, Kidney infection, Menstrual disorder, Mucosal discolouration, Nasopharyngitis, Nausea, Oropharyngeal pain, Pain, Pain in jaw, Peripheral swelling, Pneumonia, Productive cough, Pyrexia, Serum ferritin decreased, Sinusitis, Somnolence, Swelling, Temporomandibular pain and dysfunction syndrome, Urinary tract infection, |
||||
OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, OMALIZUMAB, FLUTICASONE PROPIONATE AND SALMETEROL XINAFOATE, CANDESARTAN, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, MOXIFLOXACIN HYDROCHLORIDE, MOXIFLOXACIN, MOMETASONE FUROATE, PREDNISONE, MONTELUKAST SODIUM, ALBUTEROL SULFATE, |
||||
546 | 25071015 |
US |
||
Diabetes mellitus, Hypertension, Blood cholesterol increased, Obesity, |
||||
RAVULIZUMAB, SEMAGLUTIDE, |
||||
547 | 25071038 |
US |
64 | 2 |
Infection, Hypertension, Fatigue, Dysphonia, Headache, Chest discomfort, Myalgia, Arthralgia, Dizziness, Diarrhoea, Asthenia, Epistaxis, Chest pain, Pain, Abdominal pain, Balance disorder, Hypothyroidism, |
||||
LENVATINIB, LENVATINIB, PEMBROLIZUMAB, |
||||
548 | 25071208 |
JP |
1 | |
Adrenal insufficiency, Hypertension, Hypothyroidism, |
||||
LENVATINIB, PEMBROLIZUMAB, PEMBROLIZUMAB, |
||||
549 | 25071274 |
US |
2 | |
Hypertension, Nausea, Vomiting, Pain, |
||||
ZAVEGEPANT, |
||||
550 | 25071561 |
US |
||
Product use issue, Hypertension, Cerebrovascular accident, Myocardial infarction, |
||||
TICAGRELOR, |
||||
551 | 25074090 |
2 | ||
Renal disorder, Hypertension, |
||||
SOTATERCEPT-CSRK, TREPROSTINIL, MACITENTAN, |
||||
552 | 25061275 |
US |
70 | 1 |
Glioblastoma, Hypertension, Loss of personal independence in daily activities, |
||||
RISANKIZUMAB-RZAA, |
||||
553 | 25061292 |
US |
||
Hypertension, |
||||
ESKETAMINE HYDROCHLORIDE, |
||||
554 | 25061304 |
US |
87 | 1 |
Hip arthroplasty, Fall, Loss of consciousness, Orthostatic hypotension, Dizziness, Syncope, Hypertension, Hypotension, |
||||
UPADACITINIB, |
||||
555 | 25061426 |
CA |
60 | 2 |
Asthma, Dyspnoea, Hypertension, Malaise, Middle insomnia, Nasal polyps, Restrictive pulmonary disease, Weight decreased, Wheezing, Product dose omission issue, |
||||
OMALIZUMAB, OMALIZUMAB, |
||||
556 | 25061431 |
US |
2 | |
Hypertension, Heart rate increased, Pain in jaw, |
||||
ROMOSOZUMAB-AQQG, |
||||
557 | 25061564 |
ES |
59 | 1 |
Atrial fibrillation, Vomiting, Hypertension, Dyskinesia, Tachycardia, Administration site nodule, Puncture site erythema, |
||||
MIRABEGRON, SAFINAMIDE MESYLATE, |
||||
558 | 25061648 |
US |
2 | |
Faecaloma, Condition aggravated, Mental impairment, Memory impairment, Condition aggravated, Confusional state, Constipation, Diarrhoea, Depression, Hypertension, Irritable bowel syndrome, Hypertension, Anxiety, |
||||
SEMAGLUTIDE, LOSARTAN, BUPROPION HYDROCHLORIDE, BUPROPION, |
||||
559 | 25061851 |
BE |
||
Dyskinesia, Malaise, Syncope, Hypertension, |
||||
BEMPEDOIC ACID, AMLODIPINE, TAMSULOSIN HYDROCHLORIDE, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, RAMIPRIL, |
||||
560 | 25062049 |
US |
39 | 2 |
Cholinergic syndrome, Haemorrhage intracranial, Hypertension, Drug interaction, |
||||
BUPROPION HYDROCHLORIDE, BUPROPION, DESVENLAFAXINE, DESVENLAFAXINE SUCCINATE, CLONIDINE, LISDEXAMFETAMINE, LISDEXAMFETAMINE, LEVONORGESTREL, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, FAMOTIDINE, |
||||
561 | 25062059 |
JP |
71 | 2 |
Platelet count decreased, Hypertension, |
||||
PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, ELTROMBOPAG OLAMINE, ROMIPLOSTIM, |
||||
562 | 25062356 |
IN |
64 | 1 |
Disease progression, Hypertension, Haemoglobin decreased, |
||||
ATEZOLIZUMAB, |
||||
563 | 25062373 |
GE |
2 | |
Hypertension, Cardiac flutter, |
||||
TRASTUZUMAB, |
||||
564 | 25062460 |
FR |
13 | 1 |
Hypertension, Posterior reversible encephalopathy syndrome, Inappropriate antidiuretic hormone secretion, |
||||
CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, PREDNISONE, RITUXIMAB, ALPRAZOLAM, ALPRAZOLAM, HYDROXYZINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, MORPHINE, MORPHINE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MESNA, MESNA INJECTION, MESNA, MESNA INJECTION, |
||||
565 | 25062887 |
CA |
40 | 2 |
Abdominal discomfort, Abdominal distension, Abdominal pain upper, Alopecia, Anti-cyclic citrullinated peptide antibody positive, Arthralgia, Arthropathy, Asthenia, Back injury, Blepharospasm, Blister, Blood cholesterol increased, Breast cancer stage III, Bursitis, C-reactive protein abnormal, C-reactive protein increased, Coeliac disease, Condition aggravated, Confusional state, Depression, Diarrhoea, Dizziness, Drug hypersensitivity, Drug ineffective, Drug intolerance, Drug-induced liver injury, Dry mouth, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Epilepsy, Facet joint syndrome, Fall, Fatigue, Fibromyalgia, Finger deformity, Folliculitis, Gait inability, Gastrointestinal disorder, Gastrooesophageal reflux disease, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Hepatic enzyme increased, Hepatitis, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Inflammation, Infusion related reaction, Injection site reaction, Injury, Insomnia, Irritable bowel syndrome, Joint range of motion decreased, Joint swelling, Lip dry, Liver function test increased, Liver injury, Loss of personal independence in daily activities, Lower respiratory tract infection, Lung disorder, Malaise, Memory impairment, Migraine, Mobility decreased, Muscle injury, Muscle spasms, Muscular weakness, Musculoskeletal pain, Musculoskeletal stiffness, Nail disorder, Nasopharyngitis, Nausea, Neck pain, Night sweats, Obesity, Onychomadesis, Onychomycosis, Osteoarthritis, Pain, Pain in extremity, Paraesthesia, Pemphigus, Pericarditis, Peripheral swelling, Peripheral venous disease, Pneumonia, Product label confusion, Product quality issue, Psoriatic arthropathy, Rash, Rheumatic fever, Rheumatoid arthritis, Sleep disorder, Stomatitis, Swelling, Synovitis, Systemic lupus erythematosus, Taste disorder, Therapeutic product effect decreased, Treatment failure, Type 2 diabetes mellitus, Urticaria, Vomiting, Weight increased, Wheezing, Wound, Wound infection, Adverse event, Hospitalisation, |
||||
ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, ABATACEPT, VITAMIN C, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN AND CODEINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, ERENUMAB-AOOE, ALENDRONATE SODIUM, ALENDRONATE SODIUM, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, ATOMOXETINE HYDROCHLORIDE, AZATHIOPRINE, BOTULINUM TOXIN TYPE A, BUPRENORPHINE, CALCIUM CARBONATE, ANTACID, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CHLORHEXIDINE GLUCONATE, ANTISEPTIC SKIN CLEANSER, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ETANERCEPT, ERGOCALCIFEROL, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLD, GOLIMUMAB, ADALIMUMAB, ADALIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, ADALIMUMAB-ADAZ, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, LAMOTRIGINE, LAMOTRIGINE, LAMOTRIGINE, MAGNESIUM CITRATE, MAJOR MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, CVS MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, CVS MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - LEMON, LEADER MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, BE HEALTH MAGNESIUM CITRATE ORAL SOLUTION - LEMON, FRESKARO MAGNESIUM CITRATE ORAL SOLUTION - CHERRY, LEADER MAGNESIUM CITRATE ORAL SOLUTION - GRAPE, HARRIS TEETER MAGNESIUM CITRATE ORAL SOLUTION - LEMON, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHYLPREDNISOLONE, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, MINOCYCLINE, MIRABEGRON, MIRABEGRON, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN, NAPROXEN SODIUM, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NICOTINAMIDE, MEPOLIZUMAB, APREMILAST, OXYCODONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RAMIPRIL, RANITIDINE, INFLIXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, SULFASALAZINE, APREMILAST, CANDESARTAN CILEXETIL, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, TOPIRAMATE, TOPIRAMATE SPINKLE, GOLIMUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TRAMADOL HYDROCHLORIDE, TOFACITINIB, TOFACITINIB, TOFACITINIB, |
||||
566 | 25063300 |
US |
56 | 2 |
Angina pectoris, Transient ischaemic attack, Hypothyroidism, Rectal haemorrhage, Atrial fibrillation, Hypokalaemia, Vitamin B12 deficiency, Malabsorption, Dysphagia, Gastrooesophageal reflux disease, Proctalgia, Hyperlipidaemia, Thyroid atrophy, Lymphadenopathy, Arthralgia, Myoclonus, Fibromyalgia, Osteoporosis, Hypertension, Haemorrhoids, |
||||
TOPIRAMATE, ETANERCEPT, ATORVASTATIN CALCIUM, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, LINACLOTIDE, LIDOCAINE AND GLYCERIN, LIDOCAINE, GALANTAMINE HYDROBROMIDE, LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, ZAVEGEPANT, SULFASALAZINE, METHOTREXATE SODIUM, ATENOLOL, ONABOTULINUMTOXINA, METHYLPHENIDATE HYDROCHLORIDE, METHOCARBAMOL, CLONAZEPAM, DICLOFENAC SODIUM, ERGOCALCIFEROL, DOCUSATE SODIUM, DOCUSATE SODIUM - SENNOSIDES, OMEPRAZOLE MAGNESIUM, METHYLPREDNISOLONE ACETATE, |
||||
567 | 25063428 |
CA |
10 | 1 |
Agitation, Altered state of consciousness, Hypertension, Paradoxical drug reaction, Tachycardia, |
||||
MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, CEFOTAXIME, CEFOTAXIME INJECTION, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, METRONIDAZOLE, METRONIDAZOLE TOPICAL, MOMETASONE FUROATE, MOMETASONE, OXYMETAZOLINE HYDROCHLORIDE, |
||||
568 | 25063498 |
FR |
13 | 1 |
Posterior reversible encephalopathy syndrome, Hypertension, Inappropriate antidiuretic hormone secretion, Off label use, |
||||
VINCRISTINE SULFATE, RITUXIMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, METHYLPREDNISOLONE, METHOTREXATE, METHOTREXATE SODIUM, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PREDNISONE, ALPRAZOLAM, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, MORPHINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MESNA, MESNA INJECTION, |
||||
569 | 25063521 |
CN |
68 | 1 |
Small intestinal perforation, Hypertension, |
||||
AXITINIB, |
||||
570 | 25063627 |
SI |
66 | 1 |
Pneumonia bacterial, Hypertension, Respiratory tract infection, Sepsis, |
||||
DEXAMETHASONE, DEXAMETHASONE 1.5 MG, CARFILZOMIB, CARFILZOMIB, DARATUMUMAB, |
||||
571 | 25064057 |
DE |
1 | |
Hypertension, |
||||
METOPROLOL TARTRATE, METOPROLOL, RIZATRIPTAN BENZOATE, ERENUMAB-AOOE, |
||||
572 | 25064060 |
US |
56 | 1 |
Weight increased, Peripheral swelling, Fluid retention, Hypertension, Oedema, |
||||
BUDESONIDE, CARVEDILOL, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, PREDNISONE, |
||||
573 | 25064092 |
ZA |
51 | |
Diabetes mellitus, Malaise, Hypertension, Blood cholesterol increased, |
||||
BUDESONIDE AND FORMOTEROL FUMARATE DIHYDRATE, |
||||
574 | 25064395 |
JP |
63 | 2 |
Malignant neoplasm progression, Malaise, Colitis ischaemic, Pyrexia, Hepatic function abnormal, Enterocolitis, Palmar-plantar erythrodysaesthesia syndrome, Hypertension, Platelet count decreased, White blood cell count decreased, Pyrexia, Hepatic function abnormal, |
||||
PEMBROLIZUMAB, LENVATINIB, LENVATINIB, LENVATINIB, |
||||
575 | 25064443 |
US |
56 | 2 |
Pulmonary venous hypertension, Oxygen saturation decreased, Cerebrovascular accident, Chest pain, Addison^s disease, Hypertension, |
||||
ADALIMUMAB, |
||||
576 | 25065016 |
JP |
61 | |
Gastritis erosive, Hypertension, Duodenitis, Off label use, |
||||
FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE, VALSARTAN, VALSARTAN, AMLODIPINE, NIFEDIPINE, FUROSEMIDE, |
||||
577 | 25065034 |
FR |
13 | 1 |
Hypertension, Posterior reversible encephalopathy syndrome, Inappropriate antidiuretic hormone secretion, |
||||
RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, METHOTREXATE, METHOTREXATE SODIUM, VINCRISTINE SULFATE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, PREDNISONE, METHYLPREDNISOLONE, ALPRAZOLAM, HYDROXYZINE HYDROCHLORIDE, HYDROXYZINE, MORPHINE, METOCLOPRAMIDE, METOCLOPRAMIDE HYDROCHLORIDE, ONDANSETRON HYDROCHLORIDE, ONDANSETRON, ONDANSETRON TABLETS, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, MESNA, MESNA INJECTION, |
||||
578 | 25065105 |
US |
69 | 2 |
Glaucoma, Condition aggravated, Eye disorder, Cataract, Vision blurred, Hypertension, Intentional product misuse, |
||||
TADALAFIL, |
||||
579 | 25065202 |
US |
2 | |
Adrenal insufficiency, Hypertension, Blood sodium decreased, Blood sodium decreased, Confusional state, Disorientation, Dry mouth, Anaemia, Weight decreased, |
||||
LENVATINIB, LENVATINIB, PEMBROLIZUMAB, |
||||
580 | 25065228 |
JP |
2 | |
Hypertension, Proteinuria, Decreased appetite, |
||||
LENVATINIB, LENVATINIB, LENVATINIB, LENVATINIB, |
||||
581 | 25065384 |
US |
||
Hypertension, Dizziness, |
||||
PEGVALIASE-PQPZ, PEGVALIASE-PQPZ, |
||||
582 | 25065648 |
US |
56 | 1 |
Hypertension, Fatigue, Palmar-plantar erythrodysaesthesia syndrome, Mucosal inflammation, Diarrhoea, |
||||
NIVOLUMAB, CABOZANTINIB, CABOZANTINIB, |
||||
583 | 25065757 |
US |
||
Haemorrhage, Skin discolouration, Hypertension, |
||||
APIXABAN, |
||||
584 | 25065793 |
CA |
43 | 2 |
Abdominal discomfort, Condition aggravated, Contraindicated product administered, Crohn^s disease, Decreased appetite, Deep vein thrombosis postoperative, Depression, Disability, Discomfort, Dizziness, Drug-induced liver injury, Alopecia, Drug ineffective, Drug intolerance, Duodenal ulcer perforation, Dyspepsia, Dyspnoea, Ear infection, Epilepsy, Exostosis, Fatigue, Fibromyalgia, Anti-cyclic citrullinated peptide antibody positive, Folliculitis, Foot deformity, Gait disturbance, Gait inability, General physical health deterioration, Glossodynia, Grip strength decreased, Hand deformity, Headache, Helicobacter infection, Arthropathy, Hepatic cirrhosis, Hepatic enzyme increased, Hypercholesterolaemia, Hypersensitivity, Hypertension, Hypoaesthesia, Ill-defined disorder, Impaired healing, Infection, Autoimmune disorder, Blepharospasm, Blister, Breast cancer stage III, Colitis ulcerative, Incorrect route of product administration, |
||||
ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, ADALIMUMAB, ADALIMUMAB-FKJP, ADALIMUMAB-AATY, ADALIMUMAB-ADAZ, APREMILAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, ERENUMAB-AOOE, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, LEFLUNOMIDE, LEFLUNOMIDE, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CELECOXIB, CAFFEINE CITRATE, CALCIUM, CERTOLIZUMAB PEGOL, CERTOLIZUMAB PEGOL, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIIRIZINE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE, CETIRIZINE HYDROCHLORIDE, PSEUDOEPHEDRINE HYDROCHLORIDE, CETRIMIDE, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CETIRIZINE HYDROCHLORIDE, CETIRIZINE, CETIRIZINE HYDROCHLORIDE TABLETS, CETIRIZINE HYDROCHLORIDE ALLERGY, CERTOLIZUMAB PEGOL, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, HYDROCORTISONE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, CORTISONE ACETATE, SECUKINUMAB, SECUKINUMAB, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, DOXYCYCLINE HYCLATE, DOXYCYCLINE, DOXYCLYCLINE HYCLATE, ETANERCEPT, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, ALENDRONATE SODIUM, GOLIMUMAB, ADALIMUMAB, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE ACETATE, HYDROCORTISONE BUTYRATE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, IBUPROFEN, IBUPROFEN CAPSULES 200 MG, IBUPROFEN TABLETS USP, 200MG, IBUPROFEN ORAL, IBUPROFEN 200MG, IBUPFROFEN, IBUPROFEN TABLET, FILM-COATED, IBUPROFEN 200 MG, IBUPROFEN CAPSULE, ISOPROPYL ALCOHOL, 70%ISOPROPYL ALCOHOL, ALCOHOL PREP PADS, ALCOHOL, ISOPROPYL ALCOHOL SPRAY, SARILUMAB, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LISINOPRIL, LISINOPRIL, LISINOPRIL, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, MYCOPHENOLATE MOFETIL, MYCOPHENOLATE MOFETIL HYDROCHLORIDE, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, NAPROXEN SODIUM, NAPROXEN SODIUM, COATED TABLETS, NAPROXEN SODIUM TABLET, COATED, OXYCODONE, OXYCODONE, OXYCODONE, ABATACEPT, APREMILAST, PREGABALIN, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, HYDROXYCHLOROQUINE SULFATE, HYDROXYCHLOROQUINE SULFATE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, QUETIAPINE, QUETIAPINE EXTENDED-RELEASE, RAMIPRIL, RAMIPRIL, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, RITUXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, INFLIXIMAB, SULFASALAZINE, SARILUMAB, GOLIMUMAB, GOLIMUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, USTEKINUMAB, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, SULFASALAZINE, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOCILIZUMAB, TOFACITINIB, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, USTEKINUMAB, USTEKINUMAB, ERGOCALCIFEROL, PREDNISONE, PREDNISONE, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, TOFACITINIB, PREDNISOLONE, PREDNISOLONE ORAL, PREDNISOLONE ORAL SOLUTION, |
||||
585 | 25068448 |
27 | 1 | |
Heart rate decreased, Dose calculation error, Hypertension, Incorrect dose administered, Wrong product administered, |
||||
NALOXONE, EPINEPHRINE, ADRENALINUM, |
||||
586 | 25056307 |
CA |
53 | 2 |
Blindness, Eye haemorrhage, Rectal haemorrhage, Hypertension, |
||||
UPADACITINIB, |
||||
587 | 25056338 |
US |
1 | |
Hypertension, |
||||
LUSPATERCEPT, |
||||
588 | 25056373 |
ZA |
56 | |
Hypertension, |
||||
DAPAGLIFLOZIN, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, SIMVASTATIN, CARVEDILOL, |
||||
589 | 25056391 |
AU |
59 | 1 |
Oxygen saturation decreased, Hypertension, Pyrexia, Tachycardia, Atrial pressure increased, Sputum discoloured, Lung infiltration, Dyspnoea, Incorrect dose administered, Off label use, |
||||
HUMAN IMMUNOGLOBULIN G, HUMAN IMMUNOGLOBULIN G, |
||||
590 | 25056422 |
AE |
||
Bronchiectasis, Type 2 diabetes mellitus, Hypertension, Acute sinusitis, Gastrooesophageal reflux disease, Cough, |
||||
BENRALIZUMAB, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
591 | 25056760 |
FR |
84 | 2 |
Transient aphasia, Cognitive disorder, Headache, Hypertension, |
||||
LUSPATERCEPT, |
||||
592 | 25057084 |
US |
59 | 2 |
Nephrolithiasis, Hypertension, Blood cholesterol increased, |
||||
TOCILIZUMAB, TOCILIZUMAB, GABAPENTIN, METOPROLOL TARTRATE, METOPROLOL, ROSUVASTATIN, |
||||
593 | 25057183 |
RO |
||
General physical health deterioration, Respiratory failure, Hepatic cytolysis, Hyperuricaemia, Leukocytosis, Inflammatory marker increased, Early satiety, Hypertension, Fatigue, Asthenia, Decreased appetite, Blood creatinine increased, Nausea, |
||||
TEBENTAFUSP, |
||||
594 | 25057517 |
US |
80 | 2 |
Cerebrovascular accident, Device difficult to use, Drug dose omission by device, Nervousness, Hypertension, Blood cholesterol increased, |
||||
EVOLOCUMAB, |
||||
595 | 25058306 |
JP |
62 | 2 |
Myocarditis, Hepatic function abnormal, Nausea, Hypertension, Decreased appetite, Malaise, |
||||
PEMBROLIZUMAB, DOXORUBICIN HYDROCHLORIDE, DOXORUBICIN, DICLOFENAC SODIUM, DICLOFENAC SODIUM TOPICAL, DICLOFENAC SODIUM TOPICAL GEL, 1%, DICLOFENAC, DICLOFENAC SODIUM 1%, NALDEMEDINE, TAPENTADOL HYDROCHLORIDE, OXYCODONE HYDROCHLORIDE, OXYCODONE, METHADONE HYDROCHLORIDE, METHADONE, LINACLOTIDE, |
||||
596 | 25058389 |
US |
61 | 2 |
Hypertension, Blood cholesterol increased, |
||||
TOFACITINIB, TOFACITINIB, |
||||
597 | 25058509 |
IN |
53 | 2 |
Hypertension, Metastases to central nervous system, Blood triglycerides increased, Oedema, Weight increased, Haemoglobin decreased, Neck pain, Cough, Radicular pain, Fatigue, Body mass index increased, Pollakiuria, Micturition urgency, Asthenia, Dysarthria, Memory impairment, Muscular weakness, Liver function test abnormal, |
||||
LORLATINIB, LORLATINIB, LORLATINIB, BEVACIZUMAB, METHYLPREDNISOLONE SODIUM SUCCINATE, |
||||
598 | 25058727 |
FR |
55 | 2 |
Back pain, Hypertension, Hypertriglyceridaemia, Chest discomfort, |
||||
ATORVASTATIN CALCIUM, ATORVASTATIN CALCIUM, FILM COATED, |
||||
599 | 25059030 |
NL |
64 | 1 |
Toxicity to various agents, Post-injection delirium sedation syndrome, Electrocardiogram QT prolonged, Hypertension, Muscle rigidity, Overdose, Off label use, Off label use, |
||||
OLANZAPINE PAMOATE, OLANZAPINE PAMOATE, OLANZAPINE PAMOATE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, MIDAZOLAM, MIDAZOLAM HYDROCHLORIDE, |
||||
600 | 25059251 |
US |
||
Hypertension, Anxiety, |
||||
LECANEMAB, |
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28